Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib - Kudo, M; Finn, R; Edeline, J (Eur J Cancer, 2022)
et al.